Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan has announced that its subsidiary, Genpharm ULC, has received final approval from the FDA for its abbreviated new drug application for Zaleplon capsules, 5mg and 10mg.
Subscribe to our email newsletter
Zaleplon capsules are the generic version of King Pharmaceuticals’s Sonata capsules, which had US sales of approximately $88 million for the 12 months ended March 31, 2008, according to IMS Health.
This product is shipping immediately and will be sold under the Mylan Pharmaceuticals brand, the company said.